SIR-INF-01 · SPECIALIST
InflammaSacra
Horizontal, symptom- and phase-oriented support line for pain, irritation and inflammatory tissue reactivity — applicable anywhere on the body.
Interface shown in English. Product-specific text is published in its verified source language.
What this product is for
Documents a phase-oriented routine — acute, transitional and chronic — that may accompany a regional formulation when clinically indicated, while keeping an independent formulation philosophy.
Where it is applied
The zones listed below (application field) are the possible application areas. The product can be applied across all of these zones, or more specifically in one or several of them, in consultation with your practitioner.
Application field: sacrum.
How to use it
- 01Apply to the local symptomatic tissue zone identified by the professional.
- 02Bring 1 push (airless system) of phase 1 to the area indicated by your therapist or in the application zones specific for this product.
- 03Apply the product 2 times a day in this selected area, in a thin layer.
- 04Follow up by phase 2 of this product if indicated by your therapist, following the steps in the application sequence.
Application sequence
Phase I — Neurodermal Release · 1–2 applications per day
Acute / first six weeks
Local support for pain, irritation and inflammatory tissue reactivity across muscular, tendinous, fascial, ligamentary and peripheral nerve zones. Evaluated after approximately six weeks.
Phase II — Transitus · 1–2 applications per day
Six weeks to three months
The routine shifts from inflammatory activity toward recovery and regulation: microcirculation, vegetative regulation and tissue integration.
Phase III — Integralis · 1 application per day, reviewed periodically
Beyond three months
PEA and Boswellia are lowered further and the composition moves deliberately toward chronic stabilisation and tissue integration.
What is in it
Ingredients are listed by name and function. Composition quantities are part of the controlled manufacturing documentation and are not published on this page.
Aqua baseAqua
Sets the water phase that determines spreadability across a defined surface field.
GlycerinGlycerin
Keeps the applied layer supple so the same field can be worked repeatedly without dryness on the skin surface.
Shea butterButyrospermum parkii butter
Gives the texture enough body to stay on the applied zone rather than running along the hairline.
PanthenolPanthenol
Documented as a conditioning constituent of the cutaneous topical base; contributes to a smooth, non-tacky finish.
TocopherolTocopherol
Protects the lipid fraction over the shelf life of the record so successive batches stay comparable.
Safety
- For external cutaneous topical application on intact skin only.
- Avoid contact with the eyes, mucous membranes and broken or irritated skin.
- Discontinue use if irritation occurs and consult your practitioner.
- Keep out of reach of children.
- This is a cutaneous topical composition. It is not a medicine and makes no therapeutic claim.
Storage
Store closed and upright, away from direct sunlight and heat. Use within the period stated on the package.
Questions
Is this a medicinal product?
No. SIRIAM formulations are cutaneous topical compositions. They are described by application region and composition, not directed at a therapeutic indication but rather at regulation of the nervous system. EMG validation will need to support this further in the future.
Who determines the application region?
The region is identified by a healthcare professional using anatomical landmarks and surface maps. Our documentation supports that conversation.
Can the formulation be combined with other routines?
Combination and sequencing are decided together with the treating professional. We document composition, application and response.
Record reference
- Product ID
- SIR-INF-01
- Family
- SPECIALIST
- Version
- 1.0
- Batch
- INF-2508
- Updated
- 2025-08
- Published by
- SIRIAM LAB